January 13, 2020 - Page 14 of 22

NASDAQ Companies - January 13, 2020

Aravive Receives IND Clearance for Phase 1b/Phase 2 Clinical Trial of AVB-500 in Patients with Clear Cell Renal Cell Carcinoma

HOUSTON, Jan. 13, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company, today announced that the U.S. […]

NASDAQ Companies - January 13, 2020

HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results

Preliminary full year 2019 unaudited revenue of $19.2 millionCash and cash equivalents of $33.0 million as of December 31, 2019TUCSON, […]

NASDAQ Companies - January 13, 2020

IMAC Expands Reach to Southwest Florida with Purchase of Established Practice in All Cash Transaction

BRENTWOOD, Tenn., Jan. 13, 2020 (GLOBE NEWSWIRE) — IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and […]

NASDAQ Companies - January 13, 2020

Kiniksa Announces Pipeline Progress and Reiterates 2020 Clinical Data Readouts

– Enrollment target achieved for rilonacept Phase 3 trial in recurrent pericarditis; top-line data expected in 2H 2020 –– Enrollment […]

NASDAQ Companies - January 13, 2020

AzurRx BioPharma Announces Closing of $6.9 Million Private Placement

NEW YORK, Jan. 13, 2020 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or the “Company”), a company specializing in […]

NASDAQ Companies - January 13, 2020

MediWound Expands its Distribution Agreement with GENFA MEDICA SA to Market NexoBrid in Ukraine and the Baltic States

YAVNE, Israel, Jan. 13, 2020 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to […]

NASDAQ Companies - January 13, 2020

Pixelworks and OPPO Group Sign Multi-Year Collaboration Agreement

SAN JOSE, Calif., Jan. 13, 2020 (GLOBE NEWSWIRE) — Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing […]

NASDAQ Companies - January 13, 2020

Fate Therapeutics Announces Expansion of FT516 Clinical Investigation and Publication of Preclinical Data in the Journal Blood

FT516 IND Application Cleared by FDA for Advanced Solid Tumors in Combination with PDL1-, EGFR- and HER2-targeting Therapeutic AntibodiesPublished Preclinical […]

NASDAQ Companies - January 13, 2020

PetIQ, Inc. Enters Into Definitive Agreement to Acquire the Capstar® portfolio of products from Elanco

EAGLE, Idaho, Jan. 13, 2020 (GLOBE NEWSWIRE) — PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication […]

NASDAQ Companies - January 13, 2020

Tabula Rasa HealthCare Retains 99.1% of PACE Clients to Start 2020

MOORESTOWN, N.J., Jan. 13, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare®, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the […]